Detalles de la búsqueda
1.
Structured benefit-risk assessment for enoxaparin, in the context of its label extension, for the extended treatment of deep vein thrombosis and pulmonary embolism, and prevention of its recurrence in patients with active cancer.
Pharmacoepidemiol Drug Saf
; 33(5): e5795, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38680090
2.
Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving enoxaparin thromboprophylaxis.
Eur J Intern Med
; 121: 48-55, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38030465
Resultados
1 -
2
de 2
1
Próxima >
>>